Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02274935 · ClinicalTrials.gov registry record · NA

Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02274935 is a NA study of Multiple Sclerosis that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 20 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02274935, a NA study of Multiple Sclerosis, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study examines the effect of balance and walking exercise on cognition and mobility in people with Multiple Sclerosis.

Conditions Studied

Multiple Sclerosis

Interventions

  • OTHER Exercise

Study Locations (1)

Illinois

  • Motor control research lab - Urbana

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2014-10
Est. Completion 2016-09
Phase NA

Sponsor

University of Illinois at Urbana-Champaign

129 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02274935

The ClinicalTrials.gov registry entry for NCT02274935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT02274935 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT02274935 about?

NCT02274935 is a clinical study titled "Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis". This study examines the effect of balance and walking exercise on cognition and mobility in people with Multiple Sclerosis.

What is the current status of trial NCT02274935?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-10. Estimated completion is 2016-09.

What conditions does trial NCT02274935 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT02274935?

The interventions under investigation include: Exercise (OTHER).

Who is sponsoring clinical trial NCT02274935?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02274935 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.